4.1 Article

Impact of Metabolic Syndrome on Severity of COVID-19 Illness

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers

Abhinav Grover et al.

Summary: The use of ACEIs and ARBs in COVID-19 patients is recommended by medical societies due to limited clinical evidence. Meta-analysis results showed a non-significant association of ACEI/ARB use with lower odds of developing severe disease and mortality compared to non-users. Further evaluation of individual patient factors like ACE2 polymorphisms is needed.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

Review Virology

Obesity aggravates COVID-19: A systematic review and meta-analysis

Jun Yang et al.

Summary: The study found that severe COVID-19 patients tend to have a higher body mass index compared to non-severe patients, and COVID-19 patients with obesity have a worse outcome than those without, suggesting that obesity may exacerbate the effects of COVID-19.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Endocrinology & Metabolism

Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans

John Xie et al.

Summary: In patients hospitalized for COVID-19 in New Orleans during the peak of the outbreak, clustering of hypertension, obesity, and diabetes as metabolic syndrome increased the odds of mortality, ICU admission, invasive mechanical ventilation, and acute respiratory distress syndrome compared with these comorbidities individually. Inflammatory biomarkers CRP and LDH associated with MetS were also linked with mortality.

DIABETES CARE (2021)

Article Surgery

Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity

Ali Aminian et al.

Summary: The study found that prior metabolic surgery in patients with severe obesity was associated with lower rates of hospital and ICU admission after infection with SARS-CoV-2. This suggests that weight loss and improvement in metabolic abnormalities following metabolic surgery may help reduce the risk of severe symptoms and complications in COVID-19 patients.

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Article Endocrinology & Metabolism

Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter?

Prateek Lohia et al.

Summary: This study found an association between metabolic syndrome (MetS) and severe disease outcomes in patients with COVID-19, including increased mortality, ICU admission, and need for mechanical ventilation. Patients with MetS had significantly higher mortality rates, increased ICU admissions, and greater need for mechanical ventilation compared to those without MetS.

JOURNAL OF DIABETES (2021)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Gastroenterology & Hepatology

COVID-19: Abnormal liver function tests

Qingxian Cai et al.

JOURNAL OF HEPATOLOGY (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Meta-analysis of Effect of Statins in Patients with COVID-19

Chia Siang Kow et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

Review Endocrinology & Metabolism

Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course

Rashika Bansal et al.

ENDOCRINOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Coronavirus and Cardiometabolic Syndrome JACC Focus Seminar

Jeffrey Mechanick et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Respiratory System

Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19

Cathelijne M. van Zelst et al.

BMJ OPEN RESPIRATORY RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Metabolic Syndrome and COVID-19

Hidekatsu Yanai

CARDIOLOGY RESEARCH (2020)

Article Endocrinology & Metabolism

The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients

Nasser Malekpour Alamdari et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Endocrinology & Metabolism

Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection

Timotius Ivan Hariyanto et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Letter Cardiac & Cardiovascular Systems

Adiposity is the Crucial Enhancer of COVID-19

Hidekatsu Yanai

CARDIOLOGY RESEARCH (2020)

Review Endocrinology & Metabolism

Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes

Renato Quispe et al.

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2016)

Article Pharmacology & Pharmacy

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

Davide Grassi et al.

CURRENT PHARMACEUTICAL DESIGN (2013)

Article Medicine, General & Internal

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

SG Wannamethee et al.

ARCHIVES OF INTERNAL MEDICINE (2005)